EFFICACY AND SAFETY OF TOFACITINIB RETREATMENT FOR ULCERATIVE COLITIS AFTER TREATMENT INTERRUPTION: AN UPDATE OF RESULTS FROM THE OCTAVE CLINICAL TRIALS
Julian Panés 1
Jean-Frederic Colombel 2
Severine Vermeire 3
Marla C. Dubinsky 2
Ala I. Sharara 4
Nervin Lawendy 5
Wenjin Wang
Leonardo Salese
Chinyu Su
Irene Modesto
Xiang Guo
Edward V. Loftus Jr.
1 Hospital Clínic de Barcelona, IDIBAPS, CIBERehd,Barcelona,Spain
2 Icahn School of Medicine at Mount Sinai,New York,United States
3 University Hospitals Leuven,Leuven,Belgium
4 American University of Beirut Medical Center,Beirut,Lebanon
5 Pfizer Inc,Collegeville, PA,United Sta
Session
IBD (Posters)
Conference
UEG Week Virtual 2020
Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]
Social Sharing